Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Chemicals · CIK 0000915913
$92.54
-2.04% · live
Updated
$10.89B market value
From ALBEMARLE CORP's FY2025 10-K, filed Feb 11, 2026 · read the filing
ALBEMARLE makes industrial chemicals. It took in $5.14B last year, which makes it a mid-sized company. It spends more than it earns — losing about 10 cents on every dollar of sales.
The financial picture is led by accounting, while profitability, growth and debt remain weak.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
A published bankruptcy-risk model places it in its distress range. This is a statistical reading, not a forecast.
Altman Z-Score 1.75
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Several areas of financial weakness.
From ALBEMARLE CORP's FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Gross profit
$62.5M → $668.7M
Operating income
-$1.78B → -$367.1M
Profit
-$1.18B → -$510.6M
Gross margin
1.2% → 13.0%
Measured against FY2024, from the 10-K filed Feb 11, 2026
Improved: +969.3%
$62.5M to $668.7MCritical
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: $1.41B narrower
-$1.78B to -$367.1MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
How the latest move compares (quote live), and what was published around it
ALB fell 2.04% on the latest quote. The average Materials company tracked here moved −1.21%, and the S&P 500 −1.04%. That is 0.8 points below its sector and 1.0 points below the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 4% a year for the next 10 years. Over the last 10 years it grew by about 18% a year.
The essentials
Each answered from the filings, with the numbers behind it.
No. It lost $510.6M last year, losing about 10 cents on every dollar of sales.
No. Sales shrank 4.4% last year.
No. At its current cash flow it could clear its debt in about 1.2 years. For every $1 it owes, it owns $2.39 in assets. Its operating profit does not cover its interest bill — -1.77x against the interest it owes. A bankruptcy-risk model also places it in its distress range.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It paid a dividend while making a loss, so the payment did not come out of profits — it came from reserves, borrowing or asset sales. It paid out 15% of the cash its operations generated. It has paid in each of the last 11 years.
WeakNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2025 annual filing
Last year it lost $510.6M and generated $1.28B of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 11, 2026Filing for FY2025 | FY202410-K · Feb 11, 2026Filing for FY2024 | FY202310-K · Feb 11, 2026Filing for FY2023 | FY202210-K · Feb 15, 2023Filing for FY2022 | FY202110-K · Feb 15, 2023Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $5.14B | $5.38B | $9.62B | $7.32B | $3.33B | −4.4% |
| Cost of revenue | $4.47B | $5.31B | $8.43B | $4.25B | $2.33B | −15.8% |
| Gross profit | $668.7M | $62.5M | $1.19B | $3.07B | $998.0M | +969.3% |
| Gross marginGross profit ÷ revenueWhat is this? | 13.0% | 1.2% | 12.3% | 42.0% | 30.0% | +11.8 pts |
| Selling, general and administrative | $550.0M | $618.0M | $910.0M | $524.1M | $441.5M | −11.0% |
| Operating income | -$367.1M | -$1.78B | $251.9M | $2.47B | $798.4M | +79.3% |
| Operating marginOperating income ÷ revenueWhat is this? | -7.1% | -33.0% | 2.6% | 33.7% | 24.0% | +25.9 pts |
| Interest expense | $207.7M | $165.6M | $116.1M | $123.0M | $61.5M | +25.4% |
| Income before tax | -$552.1M | -$1.76B | $246.7M | $2.43B | $133.6M | +68.7% |
| Net income | -$510.6M | -$1.18B | $1.57B | $2.69B | $123.7M | +56.7% |
| Net marginNet income ÷ revenueWhat is this? | -9.9% | -21.9% | 16.4% | 36.7% | 3.7% | +12.0 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $-4.34 | $-10.03 | $13.41 | $22.96 | $1.06 | +56.8% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| ALBALBEMARLE CORP · this page | 4.0/10 | 6/9 | -4.4% |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Was granted or awarded shares — 45 shares
Holds 13,089 shares after this filing.
Was granted or awarded shares — 5,217 shares
Holds 10,610 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Had a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join
Read the filingWrite down why you are following ALBEMARLE CORP, what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
Coverage from the last 30 days
Albemarle (ALB) Suffers a Larger Drop Than the General Market: Key Insights
Yahoo ·
Lithium’s $100 Billion Supply Gap Hands Albemarle a Domestic Moat
Benzinga ·
How Bad Would It Get If China Blocks Rare Earths to America?
Yahoo ·
Leverage Shares Is Shutting Down 13 Single-Stock Leveraged ETFs. None Drew Enough Money to Survive
Yahoo ·
Truist Securities Maintains Buy on Albemarle, Lowers Price Target to $185
Benzinga ·
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from ALB's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 11, 2026), reported under the US GAAP taxonomy. View the source filing. Total liabilities were not tagged directly and were calculated as assets minus equity.
4 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. All four had enough reported figures. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 9 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 4.0 | 6/9 | 10-K, filed Feb 11, 2026 |
| FY2024 | 2.0 | 5/9 | 10-K, filed Feb 12, 2025 |
| FY2023 | 6.0 | 5/9 | 10-K, filed Feb 15, 2024 |
| FY2022 | 8.0 | 7/9 | 10-K, filed Feb 15, 2023 |
| FY2021 | 6.0 | 5/9 | 10-K, filed Feb 22, 2022 |
| FY2020 | 5.0 | 5/9 | 10-K, filed Feb 19, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
6 of 9 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's.
1.75
In the distress zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
-3.62
Below the threshold — nothing unusual flagged
Scores above -1.78 are the ones the model associates with earnings manipulation.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: $668.8M narrower
-$1.18B to -$510.6MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +11.8 pts
1.2% to 13.0%Critical
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: +25.9 pts
-33.0% to -7.1%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +12.0 pts
-21.9% to -9.9%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: turned positive
-$992.7M to $692.5MCritical
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Improved: $5.69 narrower
-$10.03 to -$4.34Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Changed: -64.9%
$1.68B to $589.8MCritical
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Improved: +35.7%
$1.19B to $1.62BSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 5, 2026 — read it.
Improved: +199.8%
$196.9M to $590.3MCritical
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +853.0%
$47.5M to $452.9MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +1996.2%
$22.9M to $480.0MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +19.1 pts
14.8% to 33.9%Critical
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: +22.4 pts
3.6% to 26.0%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +25.8 pts
1.7% to 27.5%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +1990.4%
$0.19 to $4.07Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: -43.3%
$3.18B to $1.80BCritical
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: +31.1%
$1.33B to $1.74BSignificant
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: -9.7%
$1.81B to $1.63BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 5, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +94.0%
$233.5M to $452.9MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +50.4%
$319.1M to $480.0MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +9.6 pts
16.3% to 26.0%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +50.3%
$2.71 to $4.07Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +49.7%
$1.09B to $1.63BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +22.0%
$1.43B to $1.74BSignificant
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +17.8%
$501.0M to $590.3MSignificant
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +5.2 pts
22.3% to 27.5%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: −1.2 pts
35.1% to 33.9%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
4 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 2% and 6%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Opinions from 27 analysts covering this company, as of . Their views, not this site's.
Of 27 analysts publishing on this company, 6 say strong buy, 12 say buy and 9 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 10.0% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 16.5x — investors pay $16.5 for each $1 of trailing profit.
Nothing unusual. Its accounting patterns look like those of companies that report earnings straightforwardly.
| -9.9% |
| — |
| 0.72x |
| ECLECOLAB INC. | 9.0/10 | 6/9 | 2.2% | 12.9% | 39.71x | 1.52x |
|---|
| PPGPPG INDUSTRIES INC | 8.0/10 | 6/9 | 0.2% | 9.9% | 16.03x | 1.76x |
|---|
| IFFINTERNATIONAL FLAVORS & FRAGRANCES INC | 4.0/10 | 6/9 | -5.2% | -3.3% | — | 0.80x |
|---|
| DDDuPont de Nemours, Inc. | 6.0/10 | 6/9 | 1.9% | -11.4% | — | 0.54x |
|---|
| Median of peers | 7.0/10 | — | 1.1% | 3.3% | 27.87x | 1.16x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Was granted or awarded shares — 6,086 shares
Holds 23,601 shares after this filing.
Was granted or awarded shares — 10,867 shares
Holds 64,310 shares after this filing.
Was granted or awarded shares — 1,476 shares
Holds 1,476 shares after this filing.
Was granted or awarded shares — 1,375 shares
Holds 1,375 shares after this filing.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Quarterly report for Q2 FY2026
Revenue +31.1% · Operating margin +22.4 pts · Gross profit +199.8% — against Q2 FY2025
Published results
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join
Read the filingHad a director or senior officer leave or join · Held a shareholder vote
Read the filingQuarterly report for Q1 FY2026
Revenue +32.7% · Operating margin +14.5 pts · Gross profit +220.5% — against Q1 FY2025
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingAnnual report for FY2025
Operating margin +25.9 pts · Gross profit +969.3% · Operating income $1.41B narrower — against FY2024
Read the filingSigned a material agreement
Read the filingProxy statement for a shareholder meeting
Read the filingCompleted an acquisition or disposal · Made a Regulation FD disclosure · Reported another event
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingAnnual report for FY2025
Operating margin +25.9 pts · Gross profit +969.3% · Operating income $1.41B narrower — against FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q3 FY2025
Operating margin +65.3 pts · Gross profit turned positive · Operating income $891.8M narrower — against Q3 FY2024
Read the filingPublished results
Read the filingPrimary sources and further research